Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year SG&A expense growth
Latest
-34.18%
↓ 421% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
10.64%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -34.18% |
| 2024 | -21.65% |
| 2023 | -28.85% |
| 2022 | -9.20% |
| 2021 | 22.36% |
| 2020 | -19.08% |
| 2019 | 14.26% |
| 2018 | 72.73% |
| 2017 | 63.08% |
| 2016 | 46.93% |